APX-2039

N/A

Report date: 2024/12/04 14:22:31
NME

Base Information

Drug NameAPX-2039
Drug Alias NameAPX-2039APX2096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol-glycan biosynthesis class W protein inhibitors
TargetsPIGW
Therapy Area/IndicationsCryptococcosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmplyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmplyx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCryptococcosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A